Quarterly report pursuant to Section 13 or 15(d)

Warrants (Details)

v3.22.0.1
Warrants (Details) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2021
Warrants (Details) [Line Items]      
Warrants issued   878,260 500,000
Volatility   143.39% 107.93%
Risk-free rate   1.25% 0.29%
Warrants initial exercise price (in Dollars per share) $ 0.5   $ 0.5
Warrants and Rights Outstanding, Term 5 years   5 years
Aggregate intrinsic value of the warrants (in Dollars) $ 297,500   $ 297,500
Additional paid in capital (in Dollars)   68,722
Retained earnings (in Dollars) $ 68,722   $ 68,722
Convertible Notes [Member]      
Warrants (Details) [Line Items]      
Warrants issued   4,000,000  
Warrant [Member]      
Warrants (Details) [Line Items]      
Warrants, description     as a result of the convertible note financing, we completed in December 2021 which would allow the new noteholders to convert their debt to shares of common stock at an exercise price of $.25/share, some of the $.30 warrants outstanding in the table above had their exercise price reduced from $.30 to $.2952. This reduction of less than half a penny in the exercise price of the 25,000,000 warrants associated with our Class B Preferred stock would result in proceeds to the Company of $7,380,000 rather than $7,500,000 should all those warrants be exercised.
Series B Preferred Stock [Member]      
Warrants (Details) [Line Items]      
Converted shares 392 773  
Common stock, shares 1,960,000 3,865,000  
Warrants issued 1,960,000 3,865,000